It is a business services private limited company based in Kandivali East, Maharashtra, India, established in 2025.
2025 | Kandivali East, Maharashtra, India | ActiveUniprogen Pharmaceuticals Private Limited, a active private limited company, was established on 18 February 2025 in Kandivali East, Maharashtra, India. it holds CIN: U46497MH2025PTC440353. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Anandkumar Bhanupratap Singh (Managing Director), Sarojlata Singh (Director). It is based at A-8 Rain Basera Rd No 3, Samta Nagar Singh Estate, Kandivali East, Maharashtra, 400101.
U46497MH2025PTC440353
440353
18 February 2025
₹0.50 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Uniprogen Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anandkumar Bhanupratap Singh | Managing Director | 18 Feb 2025 | Current |
| Sarojlata Singh | Director | 18 Feb 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Uniprogen Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Uniprogen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Uniprogen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uniprogen Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Anandkumar Bhanupratap Singh was appointed as a Managing Director was appointed as a Managing Director on 18 Feb 2025 & has been associated with this company since 9 months 17 days . was completed.
Progress on Sarojlata Singh was appointed as a Director was appointed as a Director on 18 Feb 2025 & has been associated with this company since 9 months 17 days . was documented.
Progress on Uniprogen Pharmaceuticals Private Limited was registered on 18 Feb 2025 with Roc Mumbai & aged 9 months 17 days as per MCA records. was documented.
The CIN of Uniprogen Pharmaceuticals Private Limited is U46497MH2025PTC440353.
Uniprogen Pharmaceuticals Private Limited is headquartered at A-8 Rain Basera Rd No 3, Samta Nagar Singh Estate, Kandivali East, Maharashtra, 400101.
Uniprogen Pharmaceuticals Private Limited was incorporated on 18 February 2025.
The current directors of Uniprogen Pharmaceuticals Private Limited are
Uniprogen Pharmaceuticals Private Limited is unlisted.
The authorized capital of Uniprogen Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX